Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05015010
Title Alectinib in Neo-adjuvant Treatment of Stage III NSCLC (ALNEO)
Acronym ALNEO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST